Trials / Completed
CompletedNCT00615251
A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization
A Phase 3, Single-Blind, Randomized Study to Compare DR-2011 to a Progesterone Gel for Luteal Phase Supplementation for In Vitro Fertilization
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,297 (actual)
- Sponsor
- Duramed Research · Industry
- Sex
- Female
- Age
- 18 Years – 42 Years
- Healthy volunteers
- Accepted
Summary
This is a multi-center study to evaluate the effects of DR-2011 compared to a progesterone gel in women undergoing in vitro fertilization with fresh eggs. The overall study duration will be approximately 12 months and will involve ovarian suppression/stimulation protocols as well as egg retrieval.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DR-2011 | Progesterone vaginal ring for approximately 10 weeks |
| DRUG | Crinone 8% | progesterone vaginal gel for approximately 10 weeks |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2009-08-01
- Completion
- 2009-08-01
- First posted
- 2008-02-14
- Last updated
- 2013-09-13
Locations
29 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00615251. Inclusion in this directory is not an endorsement.